ಬ್ರೇನ್ ಟ್ಯೂಮರ್ (ಮೆಡುಲೋಬ್ಲಾಸ್ಟೊಮಾ)
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
ಎಲ್ಲಿಗೆ ಹೋಗಬೇಕು
ಈ trial ಗೆ 1 ಆಸ್ಪತ್ರೆ ರೋಗಿಗಳನ್ನು ಸೇರಿಸಿಕೊಳ್ಳುತ್ತಿದೆ.
ರಿಜಿಸ್ಟ್ರಿ ಸಾರಾಂಶ (ತಾಂತ್ರಿಕ)
Radiation constitutes an integral component in the management of primary brain tumors in pediatric and young adults like medulloblastoma, ependymoma, low-grade glioma, pituitary tumors, etc. A decline in neurocognitive outcomes is a multifactorial effect occurring from the primary disease as well as associated with treatments, including radiation. Since many of these tumors are highly curable, it is crucial to reduce long-term side effects, including memory loss, to improve the quality of life in these patients, leading to better rehabilitation. Radiation-induced neurocognitive deterioration i…
ಸ್ಪಾನ್ಸರ್: ಟಾಟಾ ಮೆಮೋರಿಯಲ್ ಸೆಂಟರ್
ClinicalTrials.gov ನಲ್ಲಿ NCT06779487
11 Apr 2025 ರಂದು ರಿಜಿಸ್ಟ್ರಿಯಲ್ಲಿ ಕೊನೆಯದಾಗಿ ಅಪ್ಡೇಟ್ ಮಾಡಲಾಗಿದೆ · ನಾವು 20 Oct 2026 ರಂದು ಓದಿದ್ದೇವೆ